CEUS for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This trial is testing a new imaging method called Contrast Enhanced Ultrasound (CEUS) to help doctors see blood flow changes in the spinal cord during surgery. It aims to help patients having surgery for chronic spinal cord pressure in the neck and upper back. The goal is to predict and prevent nerve damage by spotting blood flow issues early. CEUS has been used in various studies to visualize and assess blood flow in the spinal cord, including during surgery.
Research Team
Brian Saway, MD
Principal Investigator
Medical University of South Carolina
Stephen Kalhorn, MD
Principal Investigator
Medical University of South Carolina
Jessica Barley, PhD
Principal Investigator
Medical University of South Carolina
Eligibility Criteria
This trial is for adults aged 18-80 who are scheduled for posterior cervicothoracic decompression surgery to treat spinal cord compression. It's not suitable for those allergic to perflutren lipid microsphere or its components, pregnant individuals, patients with prior surgery at the same spot, or anyone unable to consent due to physical/cognitive reasons.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Definity Perflutren Lipid Microsphere Ultrasound Contrast (Ultrasound Contrast Agent)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
South Carolina Spinal Cord Injury Research Fund
Collaborator